Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Coforge Ltd
| Q2 FY2026 Earnings Conference Call
Summary : Coforge delivered exceptional Q2 FY26 results, driven by strong AI-led growth, robust order intake, and healthy margins, with a positive outlook despite macro uncertainties.
Management Perspective positive : Management repeatedly used phrases like 'exceptional quarter', 'robust health of the business', 'sustained, robust, and accelerating growth story', and 'extremely bullish' on certain geographies and teams.
Concall Report Analysis & Insights
Business Overview
- Coforge reported an exceptional Q2 FY26 with 5.9% sequential constant currency growth.
- EBIT for the quarter was 14%, reflecting robust business health and margin progression.
- The 12-month signed order book reached a record $1.63 billion, up 26.7% year-on-year.
- AI is deeply embedded in delivery models, transforming core business and BPO services.
- Employee attrition fell to 11.4%, one of the lowest in the industry.
Future Growth Prospects
- Committed to sustained, robust organic growth for the ninth consecutive year.
- AI-driven service portfolio, including proprietary platforms, fuels durable revenue growth.
- Banking, insurance, and travel verticals show positive demand trends and solid outlook.
- Healthcare and public sector outside India are growing rapidly, nearing critical mass for separate reporting.
- Cigniti acquisition provides strong cross-selling opportunities and leadership talent.
Management Insights
- Q2 FY26 was an exceptional quarter, reflecting robust business health across key operating metrics.
- Execution intensity, delivering on strategies, is Coforge's core DNA, especially with AI transformation.
- AI platforms like Code Insight AI, BlueSwan, and ForgeX are integrated into delivery models.
- Committed to a minimum 14% EBIT margin going forward, prioritizing growth over further margin expansion.
- The Cigniti acquisition has been a fantastic integration, bringing in new clients and leadership.
Risk Factors
- Uncertain macros continue to swirl around the industry.
- Hedge losses impacted reported revenue and EBIT.
- DSO has increased due to significant year-on-year growth and currency movements.
- Wage hikes will impact Q3 margins, though levers exist to partially offset.
Good To Know
- NCLT approval for Cigniti merger expected by December/January, effective April 1, 2025.
- Healthcare vertical may be carved out for separate reporting in Q1 FY27 once it reaches $100 million.
- John Speight has been added to the Board, while Gautam has resigned.
- The company aims to maintain free cash flow to PAT ratio at 70-80% going forward.
- ETR on a sustained basis is expected to be roughly 23.5% to 24%.
Key Drivers
- Exceptional Q2 FY26 financial performance.
- Record 12-month signed order book.
- Strong AI-driven service portfolio.
- Sustained robust organic growth.
Key Analyst Discussions
Competitive Environment
- AI is seen as a clear tailwind for firms that understand domain and apply relevant AI technology.
- Coforge prioritizes growth and investment over expanding margins beyond the 14% minimum.
- The company's execution mentality and AI engineering prowess drive value for clients.
Market Trends & Consumer Behavior
- Demand is increasing on the margins, with positive trends observed in banking, insurance, and travel verticals.
- EMEA experienced delays in new opportunities but is expected to recover with significant upside.
- Australia, New Zealand, Asia-Pacific, and Middle East are trending very positively.
Financial Highlights
- Management aims for sustained robust growth, minimum 14% EBIT, and 70-80% FCF to PAT.
- The gap between CC and dollar revenue growth is attributed to hedge losses, currency headwinds, and India business growth.
- DSO increase is due to 30% YoY growth and currency impact, with focus on maintaining FCF to PAT.
- Wage hikes will cause a 100-150 bps margin drop in Q3, partially offset by ESOP and depreciation.
- Discounting income on long-term contracts is recognized as 90% revenue upfront, 10% as other income.
Product Composition
- Healthcare growth is driven by AI for patient care, end-to-end platforms, and focus on payer/life science.
- Cigniti acquisition has led to strong cross-selling, with large deals already signed from its client portfolio.
- AI-led platforms are driving an upward trend in revenue per employee, though it's still early days.
Strategic Considerations
- The second half of FY26 is expected to be a robust growth period, with Q4 traditionally strong.
- The company will continue to focus on robust organic growth and strategic acquisitions.
- The increase in the 12-month executable order book is due to new deals and ramping up of previous quarter's deals.